Skip to main content
OPEN

Development of safe and sustainable by design alternatives to Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) (IA)

Last Updated: 8/19/2025Deadline: TBD€48.0M Available

Quick Facts

Programme:Horizon Europe
Call ID:HORIZON-CL4-2025-05-MATERIALS-51-two-stage
Deadline:TBD
Max funding:€48.0M
Status:
open

Email me updates on this grant

Get notified about:

  • Deadline changes
  • New FAQs & guidance
  • Call reopened
  • Q&A webinars

We'll only email you about this specific grant. Unsubscribe anytime. No spam.

💰 Funding Details

Funding Description


Key Facts

- Programme: Horizon Europe – Cluster 4 (Digital, Industry & Space)

- Call Identifier: HORIZON-CL4-2025-05-MATERIALS-51-two-stage

- Type of Action: Innovation Action (IA) – Lump-Sum Grant (Model Grant Agreement: HORIZON-AG-LS)

- Maximum EU Contribution per Project: €48 million (single-stage ceiling; the lump sum is fixed in the Grant Agreement)

- Funding Rate: 70 % of eligible costs (up to 100 % for non-profit entities) converted into a lump sum payment schedule.

- TRL Target: Advance novel PFAS-free solutions to TRL 5–7 by project end.

- Two-Stage Deadlines:

1. Stage 1 (Short Proposal): 23 Sep 2025 17:00 (Brussels)

2. Stage 2 (Full Proposal): 14 Apr 2026 17:00 (Brussels)

- Project Start Window: Q4 2026 – Q1 2027 (indicative)

- Indicative Project Duration: 48–60 months


What Will Be Funded

- R&D and Demonstration of *safe and sustainable by design* (SSbD) substitutes for PFAS in at least one of the following value chains:

* Electronics, electrical appliances & grids

* Construction technologies

* Technical textiles

* Automotive parts

- Pilot lines, scale-up trials and adaptation of existing manufacturing assets.

- Multidisciplinary assessments (toxicity, life-cycle, socio-economic, gender & health impacts) fully aligned with the SSbD framework.

- Data management & FAIR dissemination of methods, datasets and SSbD assessment results.

- SSH activities: citizen engagement, socio-economic studies, risk perception, consumer acceptance.

- Regulatory and standardisation work, incl. input to REACH restriction dossiers, EU Ecolabel, ESPR and EU Taxonomy.

- Communication, dissemination, exploitation and market-uptake actions along the entire value chain.


Eligibility Snapshot

- Consortium minimum: 3 independent legal entities from 3 different EU Member States or Associated Countries, of which at least 1 is established in an EU Member State.

- Recommended composition: industry end-users (OEMs), chemical/material suppliers, SMEs, research & technology organisations (RTOs), universities, testing labs, LCA/tox experts, SSH partners, standardisation bodies.

- In-kind contributions (e.g. pilot-line equipment) count toward the lump-sum cost model.

- Prior ongoing EU PFAS projects may participate provided there is no double funding and clear added value.


Lump-Sum Particularities

- You submit a detailed lump-sum budget at Stage 2; payments are linked to *fixed work-package deliverables* – not to real costs.

- Underspending is at the consortium’s risk, but overspending is allowed at partners’ own expense.


Compliance & Policy Alignment

- Mandatory adherence to the Commission’s SSbD framework, Gender Equality Plans (for public bodies), open-science practices and Do No Significant Harm (DNSH) principle.


---

Personalizing...

🇪🇺 Strategic Advantages

EU-Wide Advantages and Opportunities for “Development of Safe and Sustainable by Design Alternatives to PFAS (IA)”


1. Single Market Access

• 450+ million consumers and 23 million enterprises across 30+ countries (EU-27 + EEA + assoc.) provide a unique test-bed and launchpad for PFAS-free products such as technical textiles, construction materials, electronics and automotive parts.

• One CE-mark or REACH authorisation is valid EU-wide, slashing duplication costs and accelerating time-to-market for new SSbD materials.

• Public-procurement leverage: €2 trillion/year EU public spending increasingly embeds green criteria; early compliance with forthcoming PFAS restriction creates a first-mover advantage in tenders for protective equipment, infrastructure and mobility.


2. Cross-Border Collaboration and Knowledge Exchange

• Two-stage Horizon IA explicitly rewards consortia combining academia, SMEs, large industry and test beds from multiple Member States, boosting Technology Readiness Levels (TRL 5-8) faster than national schemes.

• Shared pilot lines and Open Innovation Test Beds (OITBs) reduce CapEx for scale-up; material samples can circulate tariff-free inside the customs union.

• Access to Europe’s leading SSH networks aids behavioural studies on citizen acceptance, essential for market uptake.


3. Alignment With EU Flagship Policies

• European Green Deal & Zero-Pollution Action Plan: direct contribution through PFAS phase-out and improved air/soil/water quality.

• Chemicals Strategy for Sustainability & SSbD framework: project results feed into upcoming delegated acts, influencing future market standards.

• Fit-for-55 & Circular Economy Action Plan: non-fluorinated, recyclable materials support climate and resource-efficiency targets.

• EU Ecolabel & Taxonomy Regulation: early validation of compliant chemistries opens premium finance and branding channels across the Union.


4. Regulatory Harmonisation Benefits

• Single REACH registration dossier replaces 27 national approvals; project-generated data become reference for regulators, lowering future conformity costs.

• Harmonised ESPR criteria ensure that once an alternative passes SSbD benchmarks, it gains automatic acceptance in all EU eco-design categories, from electronics to textiles.

• Coordinated standards work through CEN/CENELEC shortens certification cycles for PFAS-free cables, membranes, foams, etc.


5. Access to the EU Innovation Ecosystem

• 3 000+ Key Digital & Advanced Materials hubs (EIT, KICs, Digital Innovation Hubs) offer pilot lines, characterisation and digital twins.

• Synergies with Chips JU & Clean Hydrogen JU topics facilitate cross-sector uptake (e.g., non-fluorinated gaskets in electrolyser stacks).

• COST Actions and Marie Skłodowska-Curie networks supply trained researchers skilled in SSbD assessments, lowering HR bottlenecks.


6. Funding & Investment Synergies

• Blending with InvestEU, Innovation Fund and national Recovery & Resilience Plans can finance demo plants or retrofitting of production lines identified in the IA.

• LIFE and Interreg projects can deploy on-site remediation or citizen engagement pilots, multiplying outreach.

• Seal-of-Excellence from a strong stage-2 but unfunded proposal still unlocks €€ from ERDF/ESF+ at regional level.


7. Scale & Impact Potential

• Mandatory policy briefs to the Commission ensure outputs feed directly into ongoing PFAS restriction dossier; thus project results are primed for swift regulatory uptake and EU-wide dissemination.

• EU-level substitution roadmaps can phase out thousands of tonnes of PFAS annually, delivering measurable health & biodiversity benefits across multiple Member States simultaneously.

• By demonstrating SSbD at TRL 7-8, consortia can trigger market replication calls (HORIZON-EIC Transition, CEF) securing follow-on funding for EU-wide deployment.


8. Strategic Value Over National-Level Efforts

• Critical mass: pooling diverse industrial users (electronics, textiles, construction, automotive) yields broader structure-property datasets and avoids siloed solutions.

• Risk-sharing: Lump-sum IA distributes financial and IP risks across a pan-European value chain, de-risking individual actors.

• International signalling: EU-wide endorsement of PFAS-free technologies sets global benchmarks, opening export markets that recognise EU standards (e.g., MERCOSUR, Canada, Japan).


9. Actionable Opportunities for Applicants

1. Form a consortium spanning at least 3 Member States plus EFTA/assoc., covering the full value chain (raw-material supplier → converter → OEM → recycler) to maximise evaluation scores.

2. Engage with existing OITBs (e.g., FlexFunction2Sustain, Safechem) early to secure discounted pilot-line slots.

3. Map complementarities with regional RRF funds for plant retrofits; include letters of support from Managing Authorities in the proposal annex.

4. Allocate work-package resources for CEN standard-drafting participation; ensures that your alternative becomes the referential test method.

5. Plan joint open-access SSbD datasets compliant with FAIR; this satisfies topic requirements and positions the consortium as de-facto knowledge hub for regulators.


Bottom Line: Leveraging the integrated European market, harmonised regulation and unrivalled research infrastructure, Horizon-IA “PFAS alternatives” offers a unique springboard to commercialise safe and sustainable chemistries rapidly and at continental scale—advantages unattainable via fragmented national programmes.